Form 4: Neogenomics Director Gunn Neil Reports Stock Transactions
SEC Form 4 Filing
Director Gunn Neil reported the release of restricted stock units and subsequent ownership of common stock in Neogenomics Inc.
Summary
- On August 10, 2024, Director Gunn Neil reported a transaction involving Neogenomics Inc. common stock.
- The transaction involved the release of 11,336 restricted stock units, which converted into 11,336 shares of common stock.
- Following the transaction, Gunn Neil directly owns 11,336 shares of common stock.
- Gunn Neil also holds derivative securities including stock options and restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common practice in publicly traded companies.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in insider ownership.
Key Dates
| Date | Description |
|---|---|
| 08/10/2024 | Date of transaction: release of restricted stock units and acquisition of common stock. |
| 08/10/2024 | Restricted Stock Unit exercisable date. |
| 08/10/2033 | Stock Option (Right to Buy) Expiration Date. |
| 06/01/2025 | Stock Option (Right to Buy) exercisable date. |
| 06/01/2034 | Stock Option (Right to Buy) Expiration Date. |
| 06/01/2025 | Restricted Stock Unit exercisable date. |
| 08/13/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.